FDALive's DualVision is designed to offer the viewer quick access points to a past FDA Meeting
You control the meeting with FDALive's DualVison. From our high quality video, slides and transcripts we digitize all parts of the meeting. We then build DualVision to give you control of the meeting right from your desktop. View any presenter at any time, print out high quality slides from your printer, watch it all synced together for the full experience. We can ship DualVision to you within two business days after an FDA meeting.
- Oncologic Drugs AdComm
Meeting Date: 7/9/15-7/9/15
The committee will discuss biologics license application 125547, necitumumab injection, application submitted by Eli Lilly and Company. The proposed indication (use) for this product is in combination with gemcitabine and cisplatin for first-line treatment of patients with locally advanced or metastatic squamous non-small cell lung cancer.
|Location:||FDA Meeting Room||Related News Links:||Not Available|